(Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | (Q6)Jun 30, 2019 | (FY)Dec 31, 2018 | |
---|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | ||||||||||
Earning before tax | ---- | 98.24%-3.7M | ---- | -44.10%-209.59M | ---- | -269.50%-145.45M | ---- | -11.30%85.81M | ---- | 24.65%96.74M |
Profit adjustment | ||||||||||
Interest (income) - adjustment | ---- | 30.67%-104K | ---- | -167.86%-150K | ---- | 87.53%-56K | ---- | 33.08%-449K | ---- | -369.23%-671K |
Impairment and provisions: | --0 | -115.03%-29.39M | --0 | 64.08%195.54M | --0 | 1,125.71%119.18M | --0 | 38,792.00%9.72M | --0 | 103.61%25K |
-Impairment of property, plant and equipment (reversal) | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --303K | ---- | ---- |
-Impairmen of inventory (reversal) | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 103.70%25K |
-Impairment of trade receivables (reversal) | ---- | -115.04%-29.39M | ---- | 66.25%195.4M | ---- | 1,147.69%117.53M | ---- | --9.42M | ---- | ---- |
-Other impairments and provisions | ---- | ---- | ---- | -91.36%142K | ---- | --1.64M | ---- | ---- | ---- | ---- |
Revaluation surplus: | --0 | 175.38%6.58M | --0 | -161.58%-8.72M | --0 | --14.17M | --0 | --0 | --0 | --0 |
-Fair value of investment properties (increase) | ---- | --930K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
-Other fair value changes | ---- | 164.71%5.65M | ---- | -161.58%-8.72M | ---- | --14.17M | ---- | ---- | ---- | ---- |
Asset sale loss (gain): | --0 | 129.45%43K | --0 | -224.44%-146K | --0 | -124.06%-45K | --0 | 62.61%187K | --0 | 116.98%115K |
-Loss (gain) from sale of subsidiary company | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --115K |
-Loss (gain) on sale of property, machinery and equipment | ---- | 129.66%43K | ---- | ---145K | ---- | ---- | ---- | --187K | ---- | ---- |
-Loss (gain) from selling other assets | ---- | ---- | ---- | 97.78%-1K | ---- | ---45K | ---- | ---- | ---- | ---- |
Depreciation and amortization: | --0 | --0 | --0 | --0 | --0 | -25.17%12.53M | --0 | 61.64%16.75M | --0 | 317.61%10.36M |
-Depreciation | ---- | ---- | ---- | ---- | ---- | -25.17%12.53M | ---- | 61.64%16.75M | ---- | 317.61%10.36M |
Financial expense | ---- | -28.34%225K | ---- | 118.06%314K | ---- | -33.94%144K | ---- | --218K | ---- | ---- |
Exchange Loss (gain) | ---- | 799.41%3.57M | ---- | -2,144.00%-511K | ---- | 108.50%25K | ---- | ---294K | ---- | ---- |
Special items | ---- | -1.95%14.55M | ---- | 714.43%14.84M | ---- | -71.43%1.82M | ---- | -89.51%6.38M | ---- | 394.79%60.83M |
Operating profit before the change of operating capital | --0 | 2.39%-8.23M | --0 | -464.33%-8.43M | --0 | -98.05%2.31M | --0 | -29.32%118.32M | --0 | 84.36%167.4M |
Change of operating capital | ||||||||||
Inventory (increase) decrease | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 1,088.41%820K | ---- | 1,050.00%69K |
Accounts receivable (increase)decrease | ---- | -17.60%3.96M | ---- | 114.04%4.81M | ---- | 79.50%-34.24M | ---- | -3,274.38%-167M | ---- | 103.55%5.26M |
Accounts payable increase (decrease) | ---- | -264.71%-13.61M | ---- | 58.58%8.26M | ---- | 105.39%5.21M | ---- | -257.90%-96.68M | ---- | -32.35%61.23M |
Advance payment increase (decrease) | ---- | ---- | ---- | ---- | ---- | 35.71%-27K | ---- | 93.23%-42K | ---- | -42.86%-620K |
Cash from business operations | 1,769.27%74.58M | -85.18%-18.12M | 28.37%-4.47M | 39.41%-9.78M | 34.65%-6.24M | 88.52%-16.15M | ---9.55M | -160.68%-140.62M | --0 | 609.46%231.74M |
Other taxs | -500.00%-54K | 97.70%-25K | 99.17%-9K | 87.62%-1.09M | 87.63%-1.09M | 80.86%-8.77M | ---8.77M | -3.02%-45.84M | ---- | -4.86%-44.49M |
Special items of business | ---- | 98.31%-244K | ---- | -236.19%-14.43M | ---- | 167.27%10.59M | ---- | 347.53%3.96M | ---- | ---1.6M |
Net cash from operations | 1,764.71%74.53M | -66.91%-18.14M | 38.86%-4.48M | 56.38%-10.87M | 60.02%-7.32M | 86.63%-24.92M | 87.96%-18.32M | -199.58%-186.46M | -657.80%-152.09M | 2,017.52%187.25M |
Cash flow from investment activities | ||||||||||
Interest received - investment | 612.50%114K | -30.67%104K | -77.78%16K | 328.57%150K | 414.29%72K | -92.20%35K | -96.42%14K | -33.08%449K | 149.04%391K | 369.23%671K |
Loan receivable (increase) decrease | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --5.29M | --5.29M | ---- |
Sale of fixed assets | ---- | -98.07%145K | ---- | --7.5M | ---- | ---- | ---- | ---- | -57.21%187K | ---- |
Purchase of fixed assets | -4,090.00%-419K | 99.51%-58K | 99.88%-10K | -1,633.38%-11.74M | ---8.67M | -217.84%-677K | ---- | 86.85%-213K | -23.53%-63K | -68.75%-1.62M |
Sale of subsidiaries | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---1.02M | ---1.02M | ---- |
Acquisition of subsidiaries | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---78.4M |
Cash on investment | ---- | ---- | ---- | 105.60%20K | ---- | -141.37%-357K | -847.62%-398K | --863K | ---42K | ---- |
Net cash from investment operations | -5,183.33%-305K | 104.70%191K | 100.07%6K | -306.91%-4.07M | -2,139.06%-8.6M | -118.63%-999K | -108.11%-384K | 106.76%5.36M | 106.08%4.74M | -2,131.95%-79.35M |
Net cash before financing | 1,760.12%74.22M | -20.20%-17.95M | 71.92%-4.47M | 42.38%-14.94M | 14.87%-15.92M | 85.69%-25.92M | 87.31%-18.7M | -267.84%-181.1M | -191.28%-147.35M | 910.06%107.9M |
Cash flow from financing activities | ||||||||||
New borrowing | --8M | ---- | ---- | ---- | ---- | ---- | ---- | 7,884.62%1.01M | 25,400.00%1.01M | -103.08%-13K |
Refund | ---- | ---- | ---- | ---1.8M | ---801K | ---- | ---- | ---- | ---- | -4,588.89%-422K |
Issuing shares | ---- | ---- | ---- | -95.98%3.73M | ---- | 422.15%92.73M | 57.57%7.09M | 505.28%17.76M | --4.5M | -48.23%2.93M |
Interest paid - financing | -3.24%-3.54M | -4.63%-7.1M | -0.70%-3.43M | -4,613.19%-6.79M | -5,221.88%-3.41M | 33.94%-144K | 37.86%-64K | ---218K | ---103K | ---- |
Dividends paid - financing | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---15.53M | ---- | ---- |
Absorb investment income | ---- | --2M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Other items of the financing business | 34.00%-953K | 2.70%-2.92M | 2.76%-1.44M | -17,558.82%-3M | -84.93%-1.49M | 99.80%-17K | 83.22%-803K | ---8.62M | ---4.79M | ---- |
Net cash from financing operations | 171.93%3.51M | -2.02%-8.02M | 14.37%-4.87M | -108.49%-7.86M | -191.48%-5.69M | 1,753.89%92.57M | 900.32%6.22M | -323.97%-5.6M | 404.90%622K | -58.90%2.5M |
Effect of rate | -74.66%508K | 306.42%3.96M | 309.73%2.01M | -148.64%-1.92M | -4,083.33%-956K | -362.24%-771K | --24K | --294K | ---- | ---- |
Net Cash | 931.78%77.73M | -13.93%-25.97M | 56.76%-9.35M | -134.21%-22.8M | -73.19%-21.61M | 135.70%66.65M | 91.50%-12.48M | -269.11%-186.69M | -188.89%-146.73M | 1,624.85%110.4M |
Begining period cash | -36.23%38.75M | -28.91%60.77M | -28.91%60.77M | 335.99%85.48M | 335.99%85.48M | -90.48%19.61M | -90.48%19.61M | 115.47%206.01M | 115.47%206.01M | -7.04%95.61M |
Cash at the end | 118.96%116.99M | -36.23%38.75M | -15.08%53.43M | -28.91%60.77M | 779.68%62.92M | 335.99%85.48M | -87.93%7.15M | -90.48%19.61M | 32.26%59.28M | 115.47%206.01M |
Cash balance analysis | ||||||||||
Cash and cash equivalent balance | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | Luo Shenmei Certified Public Accountants | -- | Luo Shenmei Certified Public Accountants | -- | Luo Shenmei Certified Public Accountants | -- | Deloitte & Touche Tohmatsu Certified Public Accountants | -- | Deloitte & Touche Tohmatsu Certified Public Accountants |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data